Your browser doesn't support javascript.
loading
Megakaryocytes harbour the del(5q) abnormality despite complete clinical and cytogenetic remission induced by lenalidomide treatment.
Scharenberg, Christian; Jansson, Monika; Saft, Leonie; Hellström-Lindberg, Eva.
Affiliation
  • Scharenberg C; Department of Medicine, Centre for Haematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Jansson M; Department of Medicine, Division of Haematology, Skaraborgs Hospital Skövde, Stockholm, Sweden.
  • Saft L; Department of Medicine, Centre for Haematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Hellström-Lindberg E; Department of Pathology, Karolinska University Hospital, Solna, and Karolinska Institutet, Stockholm, Sweden.
Br J Haematol ; 180(4): 526-533, 2018 02.
Article in En | MEDLINE | ID: mdl-29377069
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Chromosomes, Human, Pair 5 / Megakaryocytes / Chromosome Deletion / Hematologic Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2018 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Chromosomes, Human, Pair 5 / Megakaryocytes / Chromosome Deletion / Hematologic Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2018 Type: Article Affiliation country: Sweden